List of bibliographic references indexed by safety
Number of relevant bibliographic references: 38.
[0-20] [
0 - 20][
0 - 38][
20-37][
20-40]
| Ident. | Authors (with country if any) | Title |
|---|
| 000424 (2014) |
Sylvia Boesch [Autriche] ; Wolfgang Nachbauer ; Caterina Mariotti ; Francesco Sacca ; Alessandro Filla ; Thomas Klockgether ; Thomas Klopstock ; Ludger Schöls ; Heike Jacobi ; Boriana Büchner ; Jennifer Müller Vom Hagen ; Lorenzo Nanetti ; Karen Manicom | Safety and tolerability of carbamylated erythropoietin in Friedreich's ataxia. |
| 000531 (2014) |
Subhashie Wijemanne [États-Unis] ; Laura J C. Wu ; Joseph Jankovic [États-Unis] | Long-term efficacy and safety of fluphenazine in patients with Tourette syndrome. |
| 000844 (2013) |
| Phase II safety, tolerability, and dose selection study of isradipine as a potential disease-modifying intervention in early Parkinson's disease (STEADY-PD). |
| 000929 (2013) |
Stewart A. Factor [États-Unis] ; Kenneth Wolski ; Daniel M. Togasaki ; Susan Huyck ; Marc Cantillon ; T W Ho ; Robert A. Hauser ; Emmanuelle Pourcher | Long-term safety and efficacy of preladenant in subjects with fluctuating Parkinson's disease. |
| 000C25 (2012) |
Robert Chinnapongse [États-Unis] ; Kristen Gullo ; Paul Nemeth ; Yuxin Zhang ; Lynn Griggs | Safety and efficacy of botulinum toxin type B for treatment of sialorrhea in Parkinson's disease: a prospective double-blind trial. |
| 000E11 (2012) |
Bruno Dubois [France] ; Eduardo Tolosa ; Regina Katzenschlager ; Murat Emre ; Andrew J. Lees ; Günther Schumann ; Emmanuelle Pourcher ; Julian Gray ; Gail Thomas ; Jina Swartz ; Timothy Hsu ; Margaret L. Moline | Donepezil in Parkinson's disease dementia: a randomized, double-blind efficacy and safety study. |
| 000F91 (2012) |
Robert Chinnapongse [États-Unis] ; Kristen Gullo [États-Unis] ; Paul Nemeth [États-Unis] ; YUXIN ZHANG [États-Unis] ; Lynn Griggs [États-Unis] | Safety and Efficacy of Botulinum Toxin Type B for Treatment of Sialorrhea in Parkinson's Disease: A Prospective Double-Blind Trial |
| 001143 (2012) |
Bruno Dubois [France] ; Eduardo Tolosa [Espagne] ; Regina Katzenschlager [Autriche] ; Murat Emre [Turquie] ; Andrew Lees (neurologue) [Royaume-Uni] ; Gunther Schumann [Allemagne] ; Emmanuelle Pourcher [Canada] ; Julian Gray [Suisse] ; Gail Thomas [Royaume-Uni] ; Jina Swartz [Royaume-Uni] ; Timothy Hsu [États-Unis] ; Margaret L. Moline [États-Unis] | Donepezil in Parkinson's Disease Dementia: A Randomized, Double-Blind Efficacy and Safety Study |
| 001565 (2011) |
Rebecca Stowe [Royaume-Uni] ; Natalie Ives [Royaume-Uni] ; Carl E. Clarke [Royaume-Uni] ; Kelly Handley [Royaume-Uni] ; Alexandra Furmston [Royaume-Uni] ; Katherine Deane [Royaume-Uni] ; J. J. Van Hilten [Pays-Bas] ; Keith Wheatley [Royaume-Uni] ; Richard Gray [Royaume-Uni] | Meta‐analysis of the comparative efficacy and safety of adjuvant treatment to levodopa in later Parkinson's disease |
| 001682 (2011) |
Joseph Jankovic [États-Unis] ; Cynthia Comella [États-Unis] ; Angelika Hanschmann [Allemagne] ; Susanne Grafe [Allemagne] | Efficacy and safety of incobotulinumtoxinA (NT 201, Xeomin) in the treatment of blepharospasm—A randomized trial |
| 001A20 (2010) |
| Safety and tolerability of high‐dosage coenzyme Q10 in Huntington's disease and healthy subjects |
| 001A21 (2010) |
Karla Eggert [Allemagne] ; David Squillacote [États-Unis] ; Paolo Barone [Italie] ; Richard Dodel [Allemagne] ; Regina Katzenschlager [Autriche] ; Murat Emre [Turquie] ; Andrew Lees (neurologue) [Royaume-Uni] ; Olivier Rascol [France] ; Werner Poewe [Autriche] ; Eduardo Tolosa [Espagne] ; Claudia Trenkwalder [Allemagne] ; Marco Onofrj [Italie] ; Fabrizio Stocchi [Italie] ; Giuseppe Nappi [Italie] ; Vladimir Kostic [Serbie] ; Jagoda Potic [Serbie] ; Evzen Ruzicka [République tchèque] ; Wolfgang Oertel [Allemagne] | Safety and efficacy of perampanel in advanced Parkinson's disease: A randomized, placebo‐controlled study |
| 001D19 (2010) |
Olivier Rascol [France] ; Paolo Barone [Italie] ; Robert A. Hauser [États-Unis] ; Yoshikuni Mizuno [Japon] ; Werner Poewe [Autriche] ; Anthony H. V. Schapira [Royaume-Uni] ; Laurence Salin [France] ; Mandy Sohr [Allemagne] ; Catherine Debieuvre [France] | Efficacy, safety, and tolerability of overnight switching from immediate‐ to once daily extended‐release pramipexole in early Parkinson's disease |
| 001F15 (2010) |
| Safety and Tolerability of High-Dosage Coenzyme Q10 in Huntington's Disease and Healthy Subjects |
| 002139 (2009) |
David Devos [France] | Patient profile, indications, efficacy and safety of duodenal levodopa infusion in advanced Parkinson's disease |
| 002218 (2009) |
Toshiyuki Tezuka [Japon] ; Tetsutaro Ozawa [Japon] ; Yuhei Takado [Japon] ; Yuichi Sato [Japon] ; Mutsuo Oyake [Japon] ; Masatoyo Nishizawa [Japon] | Megacolon in multiple system atrophy: Safety concerns related to PEG |
| 002328 (2009) |
M. Mar Trujillo-Martín [Espagne] ; Pedro Serrano-Aguilar [Espagne] ; Fernando Monton-Álvarez [Espagne] ; Romen Carrillo-Fumero [Espagne] | Effectiveness and safety of treatments for degenerative ataxias: A systematic review |
| 002519 (2009) |
M. Mar Trujillo-Martin [Espagne] ; Pedro Serrano-Aguilar [Espagne] ; Fernando Monton-Alvarez [Espagne] ; Romen Carrillo-Fumero [Espagne] | Effectiveness and Safety of Treatments for Degenerative Ataxias: A Systematic Review |
| 002B91 (2007) |
Björn Holmberg [Suède] ; Jan-Ove Johansson [Suède] ; Werner Poewe [Autriche] ; Gregor Wenning [Autriche] ; Niall P. Quinn [Royaume-Uni] ; Chris Mathias [Royaume-Uni] ; Eduardo Tolosa [Espagne] ; Adriana Cardozo [Espagne] ; Nil Dizdar [Suède] ; Olivier Rascol [France] ; Tarik Slaoui [France] | Safety and tolerability of growth hormone therapy in multiple system atrophy: A double‐blind, placebo‐controlled study |
| 002B99 (2007) |
Norman Reynolds [Niger, États-Unis] | Revisiting safety of minocycline as neuroprotection in Huntington's disease |
| 002F81 (2007) |
Richard M. Trosch [États-Unis] ; Charles H. Adler [États-Unis] ; Eric J. Pappert [États-Unis] | Botulinum toxin type B (Myobloc®) in subjects with hemifacial spasm: Results from an open‐label, dose‐escalation safety study |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i -k "safety"
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i \
-Sk "safety" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= Main
|étape= Exploration
|type= indexItem
|index= Title.i
|clé= safety
}}
| This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024 |  |
